Literature DB >> 9929057

Adjuvant therapy of cutaneous melanoma.

P A Ascierto, G Palmieri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 9929057     DOI： 10.1016/s0140-6736(05)74894-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Serial detection of circulating tumour cells by reverse transcriptase-polymerase chain reaction assays is a marker for poor outcome in patients with malignant melanoma.

Authors:  Giuseppe Palmieri; Sabrina M R Satriano; Mario Budroni; Antonio Cossu; Francesco Tanda; Sergio Canzanella; Corrado Caracò; Ester Simeone; Antonio Daponte; Nicola Mozzillo; Giuseppe Comella; Giuseppe Castello; Paolo A Ascierto
Journal:  BMC Cancer       Date:  2006-11-15       Impact factor: 4.430

Review 2.  Adjuvant therapy of melanoma with interferon: lessons of the past decade.

Authors:  Paolo A Ascierto; John M Kirkwood
Journal:  J Transl Med       Date:  2008-10-27       Impact factor: 5.531

Review 3.  Current Advancements and Novel Strategies in the Treatment of Metastatic Melanoma.

Authors:  Siddhartha Sood; Rahul Jayachandiran; Siyaram Pandey
Journal:  Integr Cancer Ther       Date:  2021 Jan-Dec       Impact factor: 3.279
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.